glp-1 receptor agonist manufacturers glp 1 companies list North America Glucagon-like Peptide-1 Agonists Companies GLP-1 Receptor Agonist Market Size

5 Medications that inhibit DPP-4 work by slowing the degradation of incretins, subsequently sustaining GLP-1 and GIP activity

Wilson JM, Nikooienejad A, Robins DA, Roell WC, Riesmeyer JS, Haupt A, Duffin KL, Taskinen MR, Ruotolo G

Most Do Not Expect Trump Administration to Lower Drug Prices for People Like Them Most of the public has heard little or nothing about recent Trump administration announcement aimed at addressing drug prices, including deals to lower what drug makers charge state Medicaid programs, a deal to lower the cost of in vitro fertilization (IVF) drugs, and plans for a website called TrumpRx that would allow people to buy drugs directly from manufacturers without using their health insurance

Pharma companies that embrace innovation, partnerships, and patient-centric strategies will lead the next era of healthcare transformation

Reviews To Read February 2026 Published in JAMA Psychiatry by Mehdi Farokhnia and Lorenzo Leggio of the NIDA IRP Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section

Take a moment as our team answers five common questions about GLP-1 medications for weight loss